Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | UBE2C |
| Upstream (Parents) |
|---|
| (<<) AKT3 → UBE2C |
| (<<) CAV1 → UBE2C |
| (<<) CCNB2 → UBE2C |
| (<<) CXCL2 → UBE2C |
| (<<) GNG11 → UBE2C |
| (<<) HSP90AA1 → UBE2C |
| (<<) IGFBP7 → UBE2C |
| (<<) ITGAV → UBE2C |
| (<<) JAK1 → UBE2C |
| (<<) KCTD12 → UBE2C |
| (<<) MAP3K12 → UBE2C |
| (<<) MYLK → UBE2C |
| (<<) SPAG5 → UBE2C |
| (<<) TSC22D1 → UBE2C |
| (<<) TUBA1B → UBE2C |
| (<<) TUBA1C → UBE2C |
| Downstream (Children) |
|---|
| UBE2C → BCL2 (>>) |
| UBE2C → BRCA1 (>>) |
| UBE2C → CAV3 (>>) |
| UBE2C → CCNB1 (>>) |
| UBE2C → DLX2 (>>) |
| UBE2C → DUSP4 (>>) |
| UBE2C → DUSP6 (>>) |
| UBE2C → DUSP9 (>>) |
| UBE2C → E2F1 (>>) |
| UBE2C → GAD1 (>>) |
| UBE2C → GNG12 (>>) |
| UBE2C → GNG4 (>>) |
| UBE2C → KRT14 (>>) |
| UBE2C → LAMB2 (>>) |
| UBE2C → LIG1 (>>) |
| UBE2C → LRP8 (>>) |
| UBE2C → MMP12 (>>) |
| UBE2C → MMP9 (>>) |
| UBE2C → MT3 (>>) |
| UBE2C → PCK2 (>>) |
| UBE2C → PLK1 (>>) |
| UBE2C → PRKCH (>>) |
| UBE2C → RDH16 (>>) |
| UBE2C → SLC7A5 (>>) |
| UBE2C → SOX2 (>>) |
| UBE2C → STAT6 (>>) |
| UBE2C → STEAP1 (>>) |
| UBE2C → TK1 (>>) |
| UBE2C → VTCN1 (>>) |
